Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Looking for participantsNCT06052618
What this trial is testing

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Who this might be right for
KSHV Inflammatory Cytokine Syndrome (KICS)Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Ended earlyNCT00127569
What this trial is testing

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Who this might be right for
HIV InfectionsGiant Lymph Node Hyperplasia
French National Agency for Research on AIDS and Viral Hepatitis 25
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Not applicableActive Not RecruitingNCT04742387
What this trial is testing

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis

Who this might be right for
Kaposi SarcomaKSHV Associated Multicentric Castleman DiseasePrimary Effusion Lymphoma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01441063
What this trial is testing

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseMulticentric Castleman DiseaseGiant Lymph Node Hyperplasia
National Cancer Institute (NCI) 8